JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al > Documents

Date Field	Doc. No.	Description (Pages)
Jul 3, 2024	292	Letter from Plaintiff to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 07/03/2024) (1)
Jul 1, 2024	291	LETTER ORDER granting request that Kendall K. Gurule be withdrawn as counsel in this case. Signed by Magistrate Judge Andre M. Espinosa on 7/1/2024. (ld, ) (Entered: 07/01/2024) (1)
Jun 28, 2024	290	MOTION to Withdraw as Attorney (Motion for Withdrawal of Attorney Kendall K. Gurule) by ASCENT PHARMACEUTICALS, INC.. (GEWIRTZ, GREGORY) (Entered: 06/28/2024) (1)
Jun 26, 2024	289	TEXT ORDER: The Court will hold a brief scheduling call, regarding the Markman hearing, at 3:30 pm on June 27. So Ordered by Judge Michael E. Farbiarz on 6/26/2024. (ro, ) (Entered: 06/26/2024) (0)
Jun 17, 2024	288	ORDER granting 284 Motion to Seal. Signed by Magistrate Judge Andre M. Espinosa on 6/17/2024. (ld, ) (Entered: 06/17/2024) (4)
Jun 14, 2024	287	STIPULATION AND ORDER OF DISMISSAL: Plaintiff JAZZ PHARMACEUTICALS RESEARCH UK LIMITED and Defendants MSN LABORATORIES PRIVATE LTD. and MSN PHARMACEUTICALS, INC. stipulate and agree that all claims, counterclaims, and affirmative defenses asserted by the Parties against each other are hereby dismissed without prejudice, and without costs or attorneys' fees to the Parties. Signed by Judge Michael E. Farbiarz on 6/14/2024. (wh) (Entered: 06/14/2024) (4)
Jun 12, 2024	286	Letter from Plaintiff to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 06/12/2024) (5)
May 21, 2024	281	REDACTION to 229 Letter,, by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (LIZZA, CHARLES) (Entered: 05/21/2024) (30)
May 21, 2024	282	REDACTION to 255 Letter,, by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (LIZZA, CHARLES) (Entered: 05/21/2024) (2)
May 21, 2024	283	REDACTION to 275 Opinion by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (LIZZA, CHARLES) (Entered: 05/21/2024) (17)
May 21, 2024	284	MOTION to Seal by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (Attachments: # 1 Certification of A. Callo, # 2 Text of Proposed Order, # 3 Certificate of Service)(CALLO, ALEXANDER) (Entered: 05/21/2024) (0)
May 21, 2024	285	Letter from from Invagen Defendant Dated January 12, 2024 (previously filed under seal). (Attachments: # 1 Declaration of Dr. Reddy (Redacted))(HENSLEY, MICHAEL) (Entered: 05/21/2024) (0)
May 14, 2024	280	LETTER ORDER granting Plaintiff's request for a one-week extension, until May 21, of the May 14 deadline to file the omnibus motion to seal and redacted versions of this related material. Signed by Magistrate Judge Andre M. Espinosa on 5/14/2024. (ld, ) (Entered: 05/14/2024) (2)
May 13, 2024	278	Letter from Paul W. Kalish to the Hon. Andre M. Espinosa, U.S.M.J.. (KALISH, PAUL) (Entered: 05/13/2024) (1)
May 13, 2024	279	Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J.. (CALLO, ALEXANDER) (Entered: 05/13/2024) (2)
May 9, 2024	277	TEXT ORDER The Court will hold a telephonic conference on August 13, 2024, at 11:30 a.m. A joint status letter shall be filed no later than August 8, 2024. To join the call, dial 973-437-5535, access code 699 424 437#. So Ordered by Magistrate Judge Andre M. Espinosa on 5/9/2024. (mp) (Entered: 05/09/2024) (0)
May 6, 2024	276	Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 05/06/2024) (1)
Apr 30, 2024	275	SEALED -- OPINION AND ORDER. Signed by Magistrate Judge Andre M. Espinosa on 4/30/2024. (sm) Modified on 5/7/2024 (sm). (Entered: 04/30/2024) (0)
Apr 26, 2024	274	LETTER ORDER granting request that Hoda Rifai-Bashjawish be withdrawn as counsel. Signed by Magistrate Judge Andre M. Espinosa on 4/26/2024. (ld, ) (Entered: 04/26/2024) (1)
Apr 25, 2024	272	MOTION to Withdraw as Attorney (Motion for Withdrawal of Hoda Rifai-Bashjawish as counsel for Defendant Ascent Pharmaceuticals, Inc.) by ASCENT PHARMACEUTICALS, INC.. (GEWIRTZ, GREGORY) (Entered: 04/25/2024) (1)
Apr 25, 2024	273	Letter from Plaintiff to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 04/25/2024) (2)
Apr 16, 2024	270	MARKMAN RESPONSE BRIEF re 266 Markman Opening Brief,,,,,,,,,,,,,,,,,,,,,,,,,,, (Attachments: # 1 Declaration of N. LoCastro, # 2 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/16/2024) (0)
Apr 16, 2024	271	MARKMAN RESPONSE BRIEF re 265 Markman Opening Brief, (Attachments: # 1 Declaration of John Coy Stull, # 2 Exhibit A to the Declaration of John Coy Stull, # 3 Exhibit B to the Declaration of John Coy Stull, # 4 Exhibit C to the Declaration of John Coy Stull, # 5 Exhibit D to the Declaration of John Coy Stull, # 6 Exhibit E to the Declaration of John Coy Stull, # 7 Exhibit F to the Declaration of John Coy Stull, # 8 Exhibit G to the Declaration of John Coy Stull, # 9 Exhibit H to the Declaration of John Coy Stull, # 10 Exhibit I to the Declaration of John Coy Stull, # 11 Exhibit J to the Declaration of John Coy Stull, # 12 Exhibit K to the Declaration of John Coy Stull, # 13 Exhibit L to the Declaration of John Coy Stull, # 14 Exhibit M to the Declaration of John Coy Stull, # 15 Exhibit N to the Declaration of John Coy Stull, # 16 Exhibit O to the Declaration of John Coy Stull, # 17 Exhibit P to the Declaration of John Coy Stull, # 18 Exhibit Q to the Declaration of John Coy Stull, # 19 Exhibit R to the Declaration of John Coy Stull, # 20 Exhibit S to the Declaration of John Coy Stull, # 21 Exhibit T to the Declaration of John Coy Stull, # 22 Exhibit U to the Declaration of John Coy Stull, # 23 Exhibit V to the Declaration of John Coy Stull, # 24 Exhibit W to the Declaration of John Coy Stull)(ECHEVERRIA, JORKEELL) (Entered: 04/16/2024) (0)
Mar 29, 2024	269	NOTICE of Appearance by KENDALL K. GURULE on behalf of ASCENT PHARMACEUTICALS, INC. (Attachments: # 1 Certificate of Service)(GURULE, KENDALL) (Entered: 03/29/2024) (0)
Feb 20, 2024	265	MARKMAN OPENING BRIEF (Attachments: # 1 Declaration of N. LoCastro, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Certificate of Service)(LIZZA, CHARLES) (Entered: 02/20/2024) (0)
Feb 20, 2024	266	MARKMAN OPENING BRIEF (Attachments: # 1 Declaration of John Coy Stull in Support of Defendants' Opening Claim Construction Brief, # 2 Exhibit A to the Declaration of John Coy Stull, # 3 Exhibit B to the Declaration of John Coy Stull, # 4 Exhibit C to the Declaration of John Coy Stull, # 5 Exhibit D to the Declaration of John Coy Stull, # 6 Exhibit E to the Declaration of John Coy Stull, # 7 Exhibit F to the Declaration of John Coy Stull, # 8 Exhibit G to the Declaration of John Coy Stull, # 9 Exhibit H to the Declaration of John Coy Stull, # 10 Exhibit I to the Declaration of John Coy Stull, # 11 Exhibit J to the Declaration of John Coy Stull, # 12 Exhibit K to the Declaration of John Coy Stull, # 13 Exhibit L to the Declaration of John Coy Stull, # 14 Exhibit M to the Declaration of John Coy Stull, # 15 Exhibit N to the Declaration of John Coy Stull, # 16 Exhibit O to the Declaration of John Coy Stull, # 17 Exhibit P to the Declaration of John Coy Stull, # 18 Exhibit Q to the Declaration of John Coy Stull, # 19 Exhibit R to the Declaration of John Coy Stull, # 20 Exhibit S to the Declaration of John Coy Stull, # 21 Exhibit T to the Declaration of John Coy Stull, # 22 Exhibit U to the Declaration of John Coy Stull, # 23 Exhibit V to the Declaration of John Coy Stull, # 24 Exhibit W to the Declaration of John Coy Stull, # 25 Exhibit X to the Declaration of John Coy Stull, # 26 Exhibit Y to the Declaration of John Coy Stull, # 27 Exhibit Z to the Declaration of John Coy Stull, # 28 Exhibit AA to the Declaration of John Coy Stull, # 29 Exhibit BB to the Declaration of John Coy Stull, # 30 Exhibit CC to the Declaration of John Coy Stull, # 31 Exhibit DD to the Declaration of John Coy Stull, # 32 Exhibit EE to the Declaration of John Coy Stull, # 33 Exhibit FF to the Declaration of John Coy Stull, # 34 Exhibit GG to the Declaration of John Coy Stull, # 35 Exhibit HH to the Declaration of John Coy Stull, # 36 Exhibit II to the Declaration of John Coy Stull, # 37 Exhibit JJ to the Declaration of John Coy Stull, # 38 Exhibit KK to the Declaration of John Coy Stull, # 39 Exhibit LL to the Declaration of John Coy Stull, # 40 Exhibit MM to the Declaration of John Coy Stull, # 41 Exhibit NN to the Declaration of John Coy Stull, # 42 Exhibit OO to the Declaration of John Coy Stull, # 43 Exhibit PP to the Declaration of John Coy Stull, # 44 Exhibit QQ to the Declaration of John Coy Stull, # 45 Exhibit RR to the Declaration of John Coy Stull, # 46 Exhibit SS to the Declaration of John Coy Stull, # 47 Exhibit TT to the Declaration of John Coy Stull, # 48 Exhibit UU to the Declaration of John Coy Stull, # 49 Exhibit VV to the Declaration of John Coy Stull, # 50 Exhibit WW to the Declaration of John Coy Stull, # 51 Exhibit XX to the Declaration of John Coy Stull, # 52 Exhibit YY to the Declaration of John Coy Stull, # 53 Exhibit ZZ to the Declaration of John Coy Stull, # 54 Exhibit AAA to the Declaration of John Coy Stull, # 55 Exhibit BBB to the Declaration of John Coy Stull, # 56 Exhibit CCC to the Declaration of John Coy Stull, # 57 Exhibit DDD to the Declaration of John Coy Stull, # 58 Exhibit EEE to the Declaration of John Coy Stull, # 59 Exhibit FFF to the Declaration of John Coy Stull, # 60 Exhibit GGG to the Declaration of John Coy Stull, # 61 Exhibit HHH to the Declaration of John Coy Stull, # 62 Exhibit III to the Declaration of John Coy Stull, # 63 Exhibit JJJ to the Declaration of John Coy Stull, # 64 Exhibit KKK to the Declaration of John Coy Stull, # 65 Exhibit LLL to the Declaration of John Coy Stull, # 66 Exhibit MMM to the Declaration of John Coy Stull, # 67 Exhibit NNN to the Declaration of John Coy Stull, # 68 Exhibit OOO to the Declaration of John Coy Stull, # 69 Exhibit PPP to the Declaration of John Coy Stull, # 70 Exhibit QQQ to the Declaration of John Coy Stull, # 71 Exhibit RRR to the Declaration of John Coy Stull, # 72 Declaration of Mahmoud Ahmed Elsohly, Ph.D., # 73 Exhibit A of Mahmoud Ahmed Elsohly, Ph.D., # 74 Exhibit B of Mahmoud Ahmed Elsohly, Ph.D., # 75 Exhibit B-1 of Mahmoud Ahmed Elsohly, Ph.D., # 76 Exhibit B-2 of Mahmoud Ahmed Elsohly, Ph.D., # 77 Exhibit B-3 of Mahmoud Ahmed Elsohly, Ph.D., # 78 Exhibit B-4 of Mahmoud Ahmed Elsohly, Ph.D., # 79 Exhibit B-5 of Mahmoud Ahmed Elsohly, Ph.D., # 80 Exhibit B-6 of Mahmoud Ahmed Elsohly, Ph.D., # 81 Exhibit B-7 of Mahmoud Ahmed Elsohly, Ph.D., # 82 Exhibit B-8 of Mahmoud Ahmed Elsohly, Ph.D., # 83 Exhibit B-9 of Mahmoud Ahmed Elsohly, Ph.D., # 84 Exhibit B-10 of Mahmoud Ahmed Elsohly, Ph.D., # 85 Exhibit B-11 of Mahmoud Ahmed Elsohly, Ph.D., # 86 Exhibit B-12 of Mahmoud Ahmed Elsohly, Ph.D., # 87 Exhibit B-13 of Mahmoud Ahmed Elsohly, Ph.D., # 88 Exhibit B-14 of Mahmoud Ahmed Elsohly, Ph.D., # 89 Exhibit B-15 of Mahmoud Ahmed Elsohly, Ph.D., # 90 Exhibit B-16 of Mahmoud Ahmed Elsohly, Ph.D., # 91 Exhibit B-17 of Mahmoud Ahmed Elsohly, Ph.D., # 92 Exhibit B-18 of Mahmoud Ahmed Elsohly, Ph.D., # 93 Exhibit B-19 of Mahmoud Ahmed Elsohly, Ph.D., # 94 Exhibit B-20 of Mahmoud Ahmed Elsohly, Ph.D., # 95 Exhibit B-21 of Mahmoud Ahmed Elsohly, Ph.D., # 96 Exhibit B-22 of Mahmoud Ahmed Elsohly, Ph.D., # 97 Exhibit B-23 of Mahmoud Ahmed Elsohly, Ph.D., # 98 Exhibit B-24 of Mahmoud Ahmed Elsohly, Ph.D., # 99 Exhibit B-25 of Mahmoud Ahmed Elsohly, Ph.D., # 100 Exhibit B-26 of Mahmoud Ahmed Elsohly, Ph.D., # 101 Exhibit B-27 of Mahmoud Ahmed Elsohly, Ph.D., # 102 Exhibit B-28 of Mahmoud Ahmed Elsohly, Ph.D., # 103 Exhibit B-29 of Mahmoud Ahmed Elsohly, Ph.D., # 104 Exhibit B-30 of Mahmoud Ahmed Elsohly, Ph.D., # 105 Exhibit B-31 of Mahmoud Ahmed Elsohly, Ph.D., # 106 Exhibit B-32 of Mahmoud Ahmed Elsohly, Ph.D., # 107 Exhibit B-33 of Mahmoud Ahmed Elsohly, Ph.D., # 108 Exhibit B-34 of Mahmoud Ahmed Elsohly, Ph.D., # 109 Exhibit B-35 of Mahmoud Ahmed Elsohly, Ph.D., # 110 Exhibit B-36 of Mahmoud Ahmed Elsohly, Ph.D., # 111 Exhibit B-37 of Mahmoud Ahmed Elsohly, Ph.D., # 112 Exhibit B-38 of Mahmoud Ahmed Elsohly, Ph.D., # 113 Exhibit B-39 of Mahmoud Ahmed Elsohly, Ph.D., # 114 Exhibit B-40 of Mahmoud Ahmed Elsohly, Ph.D., # 115 Exhibit B-41 of Mahmoud Ahmed Elsohly, Ph.D., # 116 Exhibit B-42 of Mahmoud Ahmed Elsohly, Ph.D., # 117 Exhibit B-43 of Mahmoud Ahmed Elsohly, Ph.D., # 118 Exhibit B-44 of Mahmoud Ahmed Elsohly, Ph.D., # 119 Exhibit B-45 of Mahmoud Ahmed Elsohly, Ph.D., # 120 Exhibit B-46 of Mahmoud Ahmed Elsohly, Ph.D., # 121 Exhibit B-47 of Mahmoud Ahmed Elsohly, Ph.D., # 122 Exhibit B-48 of Mahmoud Ahmed Elsohly, Ph.D., # 123 Exhibit B-49 of Mahmoud Ahmed Elsohly, Ph.D., # 124 Exhibit B-50 of Mahmoud Ahmed Elsohly, Ph.D.)(MILLER, GREGORY) (Entered: 02/20/2024) (0)
Feb 20, 2024	267	DECLARATION of Robert J. McGorrin, Ph.D. re 266 Markman Opening Brief,,,,,,,,,,,,,,,,,,,,,,,,,,, by TARO PHARMACEUTICAL INDUSTRIES LTD.. (Attachments: # 1 Exhibit 1 to the Declaration of Robert J. McGorrin, Ph.D., # 2 Exhibit 2 to the Declaration of Robert J. McGorrin, Ph.D., # 3 Exhibit 3 to the Declaration of Robert J. McGorrin, Ph.D.)(MILLER, GREGORY) (Entered: 02/20/2024) (0)
Feb 20, 2024	268	Transcript of Telephone Conference held on February 1, 2024, before Magistrate Judge Andre M. Espinosa. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 3/12/2024. Redacted Transcript Deadline set for 3/22/2024. Release of Transcript Restriction set for 5/20/2024. (adc) (Entered: 02/21/2024) (20)
Feb 15, 2024	263	Letter from Defendants to the Hon. Andre M. Espinosa, U.S.M.J. re 169 Scheduling Order,. (MILLER, GREGORY) (Entered: 02/15/2024) (1)
Feb 15, 2024	264	LETTER ORDER granting 263 request for a five-day extension of Thursday, February 15, 2024's deadline for the parties to file opening claim construction briefs. (D.I. 169) and extending the deadline to file opening claim construction briefs to Tuesday, February 20, 2024 and the deadline to complete all expert discovery relating to claim construction to March 11, 2024. Signed by Magistrate Judge Andre M. Espinosa on 2/15/2024. (ld, ) (Entered: 02/16/2024) (1)
Feb 13, 2024	262	STATEMENT Amended Joint Claim Construction and Prehearing Statement by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 02/13/2024) (0)
Feb 8, 2024	261	ORDER GRANTING LEAVE TO AMEND THE JOINT CLAIM CONSTRUCTION AND PREHEARING STATEMENT; The Amended Joint Claim Construction and Prehearing Statement shall be filed within three (3) business days of the date hereof.. Signed by Magistrate Judge Andre M. Espinosa on 2/8/2024. (ld, ) (Entered: 02/08/2024) (2)
Feb 7, 2024	260	Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(LIZZA, CHARLES) (Entered: 02/07/2024) (0)
Feb 5, 2024	259	NOTICE of Appearance by JORKEELL ECHEVERRIA on behalf of API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. (ECHEVERRIA, JORKEELL) (Entered: 02/05/2024) (1)
Feb 1, 2024	258	TEXT ORDER The Court will hold a telephonic status conference on May 9, 2024, at 3:00 p.m. Dial 973-437-5535, access code 680 363 193#. A joint status letter shall be filed by May 6, 2024. So Ordered by Magistrate Judge Andre M. Espinosa on 2/1/2024. (mp) (Entered: 02/01/2024) (0)
Jan 29, 2024	257	Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 01/29/2024) (2)
Jan 25, 2024	256	ANSWER to Counterclaim Answer to the InvaGen Defendants' Counterclaims by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 01/25/2024) (0)
Jan 16, 2024	255	Letter from Plaintiff to the Hon. Andre M. Espinosa, U.S.M.J. re 254 Letter,,. (LIZZA, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 01/16/2024) (0)
Jan 12, 2024	254	Letter from Invagen Defendants. (Attachments: # 1 Declaration of Dr. Reddy)(HENSLEY, MICHAEL)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 01/12/2024) (0)
Jan 11, 2024	252	OPINION AND ORDER. Signed by Judge Michael E. Farbiarz on 1/11/2024. (ld, ) (Entered: 01/11/2024) (17)
Jan 11, 2024	253	ORDER that the Plaintiff's motion to dismiss the Defendants' counterclaims, to the extent those counterclaims rest on the "priority date" theory, is denied.. Signed by Judge Michael E. Farbiarz on 1/11/2024. (ld, ) (Entered: 01/11/2024) (2)
Jan 2, 2024	250	Letter from Michael T. Hensley, Esq.. (HENSLEY, MICHAEL) (Entered: 01/02/2024) (3)
Jan 2, 2024	251	ORDER OF WITHDRAWAL OF PRO HAC VICE COUNSEL KATHERINE TEAL LEONARD, ESQ. AND REQUEST FOR REMOVAL FROM RECEIVING NOTICE OF ELECTRONIC FILING. Signed by Magistrate Judge Andre M. Espinosa on 1/2/2023. (ld, ) (Entered: 01/03/2024) (2)
Dec 21, 2023	249	STATEMENT Joint Claim Construction and Prehearing Statement by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 12/21/2023) (0)
Dec 19, 2023	248	STIPULATION AND ORDER regarding Caption Change. The Clerk of the Court is directed to amend the caption in C.A. No. 23-CV-18-MEF-AME to reflect the name change as to Plaintiff Jazz Pharmaceuticals Research UK Limited f/k/a GW Research Limited. Signed by Judge Michael E. Farbiarz on 12/19/2023. (dam) (Entered: 12/19/2023) (5)
Dec 18, 2023	247	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 12/18/2023) (6)
Dec 11, 2023	244	STIPULATION AND ORDER OF DISMISSAL as to Defendant Alkem Laboratories Ltd.. Signed by Judge Michael E. Farbiarz on 12/11/2023. (ld, ) (Entered: 12/11/2023) (3)
Dec 11, 2023	245	Notice to be terminated and withdraw from Notices of Electronic filing as to case. (EKINER, KAAN) (Entered: 12/11/2023) (2)
Dec 11, 2023	246	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney KAAN EKINER terminated. (EKINER, KAAN) (Entered: 12/11/2023) (2)
Dec 8, 2023	243	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 12/08/2023) (4)
Nov 28, 2023	242	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney ADAM JOSHUA HOROWITZ terminated. (HOROWITZ, ADAM) (Entered: 11/28/2023) (2)
Nov 27, 2023	238	Notice to be terminated and withdraw from Notices of Electronic filing as to case. (WALSH, LIZA) (Entered: 11/27/2023) (2)
Nov 27, 2023	239	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney CHRISTINE INTROMASSO GANNON terminated. (GANNON, CHRISTINE) (Entered: 11/27/2023) (2)
Nov 27, 2023	240	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney LAUREN RUTH MALAKOFF terminated. (MALAKOFF, LAUREN) (Entered: 11/27/2023) (2)
Nov 27, 2023	241	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney LIZA M. WALSH terminated. (WALSH, LIZA) (Entered: 11/27/2023) (2)
Nov 22, 2023	237	STIPULATION AND ORDER OF DISMISSAL without prejudice as to Teva Pharmaceuticals, Inc.. Signed by Judge Michael E. Farbiarz on 11/22/2023. (ld, ) (Entered: 11/22/2023) (2)
Nov 21, 2023	236	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 11/21/2023) (3)
Nov 16, 2023	234	TEXT ORDER Having heard argument on November 1, 2023, concerning the dispute raised in the letter at DE 229 , the Court takes the matter under advisement. The next telephonic status conference will be held on February 1, 2024, at 2:30 p.m. A joint status letter shall be filed at least three business days prior. To join the conference, dial 866-434-5269 and enter access code 1874589. So Ordered by Magistrate Judge Andre M. Espinosa on 11/16/2023. (mp) (Entered: 11/16/2023) (0)
Nov 15, 2023	235	STIPULATION AND ORDER OF DISMISSAL without prejudice as to PADAGIS US LLC. Signed by Judge Michael E. Farbiarz on 10/30/2023. (ld). (Entered: 11/16/2023) (3)
Nov 13, 2023	233	LETTER ORDER that the parties file one omnibus motion to seal this related material, together with the redacted versions of all submissions subject to the sealing motion, within fourteen (14) days following resolution of the dispute set forth in GW's October 27 Letter.. Signed by Magistrate Judge Andre M. Espinosa on 11/13/2023. (ld, ) (Entered: 11/14/2023) (2)
Nov 10, 2023	231	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (CALLO, ALEXANDER) (Entered: 11/10/2023) (2)
Nov 6, 2023	232	Transcript of Telephone Conference held on November 1, 2023, before Magistrate Judge Andre M. Espinosa. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 11/27/2023. Redacted Transcript Deadline set for 12/7/2023. Release of Transcript Restriction set for 2/5/2024. (adc) (Entered: 11/13/2023) (38)
Oct 28, 2023	230	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 10/28/2023) (4)
Oct 27, 2023	229	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(LIZZA, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 10/27/2023) (0)
Oct 17, 2023	228	Corporate Disclosure Statement by INVAGEN PHARMACEUTICALS, INC. identifying Cipla (EU) Limited; Cipla Ltd. as Corporate Parent.. (HENSLEY, MICHAEL) (Entered: 10/17/2023) (2)
Oct 15, 2023	227	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney MICHAEL K. BELOSTOCK terminated. (BELOSTOCK, MICHAEL) (Entered: 10/15/2023) (2)
Oct 12, 2023	225	Corporate Disclosure Statement by BIOPHORE PHARMA, INC.. (SHELHOFF, DMITRY) (Entered: 10/12/2023) (4)
Oct 12, 2023	226	Corporate Disclosure Statement by BIOPHORE PHARMA, INC.. (SHELHOFF, DMITRY) (Entered: 10/12/2023) (4)
Oct 11, 2023	224	Letter from InvaGen Defendants to the Hon. Michael E. Farbiarz, U.S.D.J. re 217 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53. (HENSLEY, MICHAEL) (Entered: 10/11/2023) (3)
Oct 10, 2023	222	Letter from Michael Hensley on behalf of Invagen Defendants. (HENSLEY, MICHAEL) (Entered: 10/10/2023) (1)
Oct 10, 2023	223	TEXT ORDER: The request to file tomorrow at ECF 222 is granted. So Ordered by Judge Michael E. Farbiarz on 10/10/2023. (ro, ) (Entered: 10/10/2023) (0)
Oct 9, 2023	220	NOTICE by API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. Regarding Affirmative Defense 53 (HENSLEY, MICHAEL) (Entered: 10/09/2023) (2)
Oct 9, 2023	221	Letter from Michael T. Hensley, Esq.. (HENSLEY, MICHAEL) (Entered: 10/09/2023) (2)
Oct 3, 2023	215	Notice of Request by Pro Hac Vice J. Coy Stull, Esq. and Katherine Teal Leonard, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14757812.) (HENSLEY, MICHAEL) (Entered: 10/03/2023) (2)
Oct 3, 2023	216	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J. re 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53. (LIZZA, CHARLES) (Entered: 10/03/2023) (1)
Oct 3, 2023	217	MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53 by GW RESEARCH LIMITED. (Attachments: # 1 Brief, # 2 Declaration of N. LoCastro, # 3 Text of Proposed Order, # 4 Certificate of Service)(LIZZA, CHARLES). (Entered: 10/03/2023) (0)
Oct 3, 2023	218	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J. re 217 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53. (LIZZA, CHARLES) (Entered: 10/03/2023) (3)
Oct 2, 2023	219	Transcript of Motion Hearing held on September 14, 2023, before Judge Michael E. Farbiarz. Court Reporter: Lisa Larsen (973-776-7741). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter due, but not filed, by 10/23/2023. Redacted Transcript Deadline set for 11/2/2023. Release of Transcript Restriction set for 1/1/2024. (adc) (Entered: 10/05/2023) (69)
Sep 26, 2023	214	ORDER advising the Counterclaim-Defendant that if it wishes to eliminate the extrinsic evidence, it shall file on or before October 3, 2023: (1) a motion to withdraw its current motion in its entirety and (2) a new motion. The new motion shall attach a red-line comparison with the previously filed motion, and the new motion shall include only such changes as are strictly and narrowly necessary to eliminate the extrinsic evidence, and no other changes. Signed by Judge Michael E. Farbiarz on 9/26/2023. (dam) (Entered: 09/26/2023) (1)
Sep 25, 2023	213	ORDER ON CONSENT Granting Leave to Appear Pro Hac Vice as to John Coy Stull, Esq., and Katherine Teal Leonard, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 9/25/2023. (ld, ) (Entered: 09/25/2023) (3)
Sep 22, 2023	211	MOTION for Leave to Appear Pro Hac Vice of Katherine Teal Leonard, Esq. and John Coy Stull, Esq. by API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC.. (Attachments: # 1 Certification of M. Hensley, # 2 Declaration of K. Leonard, # 3 Declaration of J. Coy-Stull, # 4 Text of Proposed Order)(HENSLEY, MICHAEL) (Entered: 09/22/2023) (0)
Sep 21, 2023	212	LETTER ORDER that InvaGen hereby withdraws Affirmative Defense 53 and GW hereby withdraws the corresponding portion of its motion, without prejudice to InvaGen filing a more detailed Affirmative Defense 53 on or before October 9.. Signed by Judge Michael E. Farbiarz on 9/21/2023. (ld, ) (Entered: 09/22/2023) (1)
Sep 20, 2023	208	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 09/20/2023) (1)
Sep 20, 2023	209	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 09/20/2023) (3)
Sep 20, 2023	210	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 09/20/2023) (2)
Sep 18, 2023	206	TEXT ORDER The parties having reported their dispute concerning the Discovery Confidentiality Order ("DCO") has been resolved and also having submitted an agreed-to DCO, see DE 204 , the dispute first raised in the letter of July 19, 2023, DE 184 , is moot. The Court has reviewed the proposed DCO at DE 204 and will proceed to enter it on the docket. So Ordered by Magistrate Judge Andre M. Espinosa on 9/18/2023. (mp) (Entered: 09/18/2023) (0)
Sep 18, 2023	207	Discovery Confidentiality Order. Signed by Magistrate Judge Andre M. Espinosa on 9/18/2023. (jd, ) (Entered: 09/18/2023) (0)
Sep 15, 2023	202	TEXT ORDER: At oral argument earlier today the Court reserved decision with respect to the pending motion at ECF 158. In addition, and as discussed at the oral argument, the parties shall file three letters, each on or before September 18, and each no longer than two pages. First, counsel for the Counterclaim Defendants shall file a letter setting out their position with respect to: (1) converting their motion (as to the inequitable conduct argument related to the prosecution of the 673 and 674 patents) into a Rule 56 motion, and (2) dismissing their current motion as to that aspect of the inequitable conduct counterclaim. Second, the parties shall file a joint letter that sets out their positions as to whether judicial notice can and should be taken as to whether all of the small entity representations to the Patent Office, as described throughout the relevant counterclaims, come in the form of affidavits or their sworn equivalents. Third, the parties shall file a joint letter that sets out their positions on the Counterclaim Defendants withdrawing their motion to dismiss Affirmative Defense 53 without prejudice to the Counterclaim Plaintiffs filing a more detailed Affirmative Defense 53 on or before October 9. So Ordered by Judge Michael E. Farbiarz on 9/15/23. (ro, ) (Entered: 09/15/2023) (0)
Sep 15, 2023	203	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 09/15/2023) (2)
Sep 15, 2023	204	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 09/15/2023) (27)
Sep 15, 2023	205	LETTER ORDER that the date to submit the three letters set forth in ECF No. 202 is hereby extended from September 18 to September 20, 2023. Signed by Judge Michael E. Farbiarz on 9/15/2023. (ld, ) (Entered: 09/16/2023) (2)
Sep 14, 2023	201	Minute Entry for proceedings held before Judge Michael E. Farbiarz: Motion Hearing held on 9/14/2023 (Court Reporter, Lisa Larsen (973-776-7741)) (ro, ) (Entered: 09/14/2023) (1)
Sep 13, 2023	200	ORDER GRANTING INVAGEN PHARMACEUTICALS, INC., CIPLA LTD., CIPLA USA, INC., AND API PHARMA TECH LLC'S REQUEST TO CHANGE SUPERVISION OF JAYASHREE MITRA, ESQ'S PRO HAC VICE ADMISSION; that Jayashree Mitra, Esq.'s pro hac vice admission shall be hereby supervised by Michael T. Hensley in this matter. Signed by Magistrate Judge Andre M. Espinosa on 9/13/2023. (ld). (Entered: 09/13/2023) (2)
Sep 12, 2023	198	NOTICE of Appearance by MICHAEL T. HENSLEY on behalf of API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. (HENSLEY, MICHAEL) (Entered: 09/12/2023) (1)
Sep 12, 2023	199	Letter from Michael T. Hensley, Esq.. (Attachments: # 1 Certification of M. Hensley, # 2 Text of Proposed Order)(HENSLEY, MICHAEL) (Entered: 09/12/2023) (0)
Sep 11, 2023	196	ORDER OF WITHDRAWAL OF PRO HAC VICE COUNSEL JEFF E. SCHWARTZ, ESQ. AND HOWARD S. SUH, ESQ. AND REQUEST FOR REMOVAL FROM RECEIVING NOTICE OF ELECTRONIC FILING. Signed by Magistrate Judge Andre M. Espinosa on 9/11/2023. (ld, ) (Entered: 09/11/2023) (2)
Sep 11, 2023	197	CONSENT ORDER GRANTING INVAGEN PHARMACEUTICALS, INC., CIPLA LTD., CIPLA USA, INC., AND API PHARMA TECH LLC'S SUBSTITUTION OF ATTORNEY; that Carlton Fields, P.A. shall be substituted as attorneys of record in this matter in place and instead of Fox Rothschild LLP; that Fox Rothschild LLP is withdrawn as counsel of record in this matter for Defendants Invagen Pharmaceuticals, Inc., Cipla Ltd., Cipla USA, Inc., and API Pharma Tech LLC. Signed by Magistrate Judge Andre M. Espinosa on 9/11/2023. (ld, ) (Entered: 09/11/2023) (2)
Sep 8, 2023	194	Letter from Michael T. Hensley, Esq.. (Attachments: # 1 Text of Proposed Order for Substitution)(HENSLEY, MICHAEL) (Entered: 09/08/2023) (0)
Sep 8, 2023	195	Letter from Paul W. Kalish to the Honorable Andre M. Espinosa, U.S.M.J. re: InvaGen Defendants' Notice of Withdrawal of Pro Hac Vice Attorneys Jeff E. Schwartz, Esq. and Howard S. Suh, Esq.. (Attachments: # 1 Notice and Proposed Order)(KALISH, PAUL) (Entered: 09/08/2023) (0)
Sep 7, 2023	193	TEXT ORDER: As the motion at ECF 159 was mooted by the stipulation at ECF 175, the Court will hear oral argument on September 14th at 11:00 a.m. only as to the motion at ECF 158. So Ordered by Judge Michael E. Farbiarz on 9/7/2023. (ro, ) (Entered: 09/07/2023) (0)
Aug 29, 2023	192	Transcript of Telephone Conference held on August 23, 2023, before Magistrate Judge Andre M. Espinosa. Transcriber: King Transcription Services (973-237-6080). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Transcription Agency due, but not filed, by 9/19/2023. Redacted Transcript Deadline set for 9/29/2023. Release of Transcript Restriction set for 11/27/2023. (adc) (Entered: 08/31/2023) (50)
Aug 28, 2023	191	LETTER ORDER: Telephone Status Conference adjourned to 11/1/2023 at 11:00 AM before Magistrate Judge Andre M. Espinosa. A joint status letter shall be filed no later than October 27, 2023. Signed by Magistrate Judge Andre M. Espinosa on 8/28/2023. (ld, ) (Entered: 08/28/2023) (1)
Aug 25, 2023	190	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 08/25/2023) (1)
Aug 23, 2023	189	ORDER that, no later than 8/31/2023, the parties shall exchange disclosures identifying their respective "designated in-house counsel" as defined by the proposed DCO's Paragraph 7(g) and describing generally each individual's involvement, if any, with preparing, reviewing, and/or amending FDA petitions. The parties shall thereafter meet and confer in a good faith effort to resolve or narrow their dispute concerning the inclusion of the FDA bar in the proposed DCO. No later than 9/15/2023, the parties shall file either (1) a joint letter advising they have reached a mutually agreeable resolution or (2) a supplemental dispute letter. Signed by Magistrate Judge Andre M. Espinosa on 8/23/2023. (dam) (Entered: 08/23/2023) (2)
Aug 22, 2023	188	TEXT ORDER: Oral argument scheduled in this matter for September 14, 2023 will now commence at 11:00 a.m. So Ordered by Judge Michael E. Farbiarz on 8/22/2023. (ro, ) (Entered: 08/22/2023) (0)
Aug 21, 2023	187	TEXT ORDER: The Court will hear oral argument on the fully briefed motions at docket entries 158 & 159 on Thursday, September 14th at 2:00 PM. The hearing will be held in courtroom 3, Frank Lautenberg PO & Courthouse, 2 Federal Square. So Ordered by Judge Michael E. Farbiarz on 8/21/2023. (ro, ) (Entered: 08/21/2023) (0)
Aug 17, 2023	186	TEXT ORDER The Court will hold a telephonic conference on Wednesday, August 23, 2023, at 10:00 a.m., to address the dispute letter filed at DE 184 . To join the conference, dial 866-434-5269 and enter access code 1874589#. So Ordered by Magistrate Judge Andre M. Espinosa on 8/17/2023. (mp) (Entered: 08/17/2023) (0)
Aug 4, 2023	185	NOTICE of Appearance by TIMOTHY P. GONZALEZ on behalf of TARO PHARMACEUTICAL INDUSTRIES LTD. (GONZALEZ, TIMOTHY) (Entered: 08/04/2023) (2)
Jul 19, 2023	183	LETTER ORDER granting 182 Defendants / Counterclaim-Plaintiffs' Request for a four (4) day extension of the deadline to serve their non-infringement and invalidity contentions from 7/20/2023 to 7/24/2023. The deadline for Plaintiff to serve its infringement contentions and invalidity contentions shall be extended from 10/13/2023 to 10/17/2023. Signed by Magistrate Judge Andre M. Espinosa on 7/19/2023. (dam) (Entered: 07/19/2023) (2)
Jul 19, 2023	184	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 07/19/2023) (30)
Jul 18, 2023	181	LETTER ORDER granting the parties 180 request for a two-day extension of the deadline until Wednesday, July 19, 2023 to submit a Proposed Discovery Confidentiality Order. Signed by Magistrate Judge Andre M. Espinosa on 7/18/2023. (ld, ) (Entered: 07/18/2023) (1)
Jul 18, 2023	182	Letter from Paul W. Kalish to the Honorable Andre M. Espinosa, U.S.M.J.. (KALISH, PAUL) (Entered: 07/18/2023) (2)
Jul 17, 2023	180	Letter from Defendant Teva Pharmaceuticals, Inc. Requesting Two-Day Extension to Submit Proposed Discovery Confidentiality Order. (WALSH, LIZA) (Entered: 07/17/2023) (1)
Jul 14, 2023	179	MEMORANDUM in Support filed by GW RESEARCH LIMITED re 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53 (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 07/14/2023) (0)
Jul 7, 2023	178	BRIEF in Opposition filed by API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. re 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53 (Attachments: # 1 Certificate of Service)(KALISH, PAUL) (Entered: 07/07/2023) (0)
Jul 6, 2023	177	LETTER ORDER granting 176 request for an extension until July 17, 2023 of the deadline for the parties to submit a proposed Discovery Confidentiality Order. Signed by Magistrate Judge Andre M. Espinosa on 7/6/2023. (ld, ) (Entered: 07/06/2023) (1)
Jul 5, 2023	176	Letter from Liza M. Walsh to the Honorable Andre M. Espinosa, U.S.M.J. re 169 Scheduling Order,. (WALSH, LIZA) (Entered: 07/05/2023) (1)
Jun 29, 2023	175	STIPULATION AND ORDER OF DISMISSAL WITHOUT PREJUDICE; Counts LXI, LXII, LXIII, and LXXV of ECF No. 1 are hereby dismissed without prejudice; Counterclaim Counts I-IX, XLIII-XLV and LX-LXII of ECF No. 110 are hereby dismissed without prejudice; All Counterclaim Counts asserted against Counterclaim-Defendants GW Pharmaceuticals Limited, GW Pharma Limited, Greenwich Biosciences, Inc., and Jazz Pharmaceuticals, Inc. are hereby dismissed without prejudice; Counterclaim-Defendants GW Pharmaceuticals Limited, GW Pharma Limited, Greenwich Biosciences, Inc., and Jazz Pharmaceuticals, Inc. are hereby dismissed without prejudice as parties in the above-captioned matter. Signed by Judge Michael E. Farbiarz on 6/29/2023. (ld, ) (Entered: 06/30/2023) (4)
Jun 28, 2023	174	Letter from GW to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 06/28/2023) (6)
Jun 22, 2023	172	Letter from Paul W. Kalish to the Honorable Michael E. Farbiarz, U.S.D.J.. (KALISH, PAUL) (Entered: 06/22/2023) (6)
Jun 22, 2023	173	STIPULATION AND ORDER REGARDING TIME TO FILE OPPOSITION AND REPLY BRIEFING REGARDING PENDING MOTIONS TO DISMISS [DKT. NOS. 158 AND 159]; The InvaGen Defendants' opposition briefing to the Motions to Dismiss shall be filed by July 7, 2023. The Counterclaim Defendants' reply briefing to the Motions to Dismiss shall be filed by July 14, 2023. Signed by Judge Michael E. Farbiarz on 6/22/2023. (ld, ) (Entered: 06/23/2023) (4)
Jun 20, 2023	170	ANSWER to Counterclaim GW Research Limited's Answer to Apotex Inc.'s Counterclaims by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 06/20/2023) (0)
Jun 20, 2023	171	NOTICE of Appearance by ADAM JOSHUA HOROWITZ on behalf of TEVA PHARMACEUTICALS, INC. (HOROWITZ, ADAM) (Entered: 06/20/2023) (3)
Jun 16, 2023	167	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 06/16/2023) (6)
Jun 16, 2023	168	STIPULATION AND ORDER REGARDING TIME TO FILE OPPOSITION AND REPLY BRIEFING REGARDING PENDING MOTIONS TO DISMISS [DKT. NOS. 158 AND 159]; The InvaGen Defendants' opposition briefing to the Motions to Dismiss shall be filed by June 23, 2023. The Counterclaim Defendants' reply briefing to the Motions to Dismiss shall be filed by June 30, 2023. The motion day for the Motions to Dismiss shall be set to July 17, 2023. Signed by Judge Michael E. Farbiarz on 6/16/2023. (ld, ) (Entered: 06/16/2023) (3)
Jun 16, 2023	N/A	Reset Deadlines as to 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53, 159 MOTION to Dismiss Non-Patentee Counterclaim-Defendants' Motion to Dismiss Pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and 12(b)(6). Motion reset for 7/17/2023 before Judge Michael E. Farbiarz. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ld, ) (Entered: 06/16/2023) (0)
Jun 16, 2023	169	PRETRIAL SCHEDULING ORDER: Telephone Status Conference set for 9/5/2023 at 11:00 AM before Magistrate Judge Andre M. Espinosa. Amended Pleadings due by 2/14/2024. Fact Discovery due by 9/6/2024. Joinder of Parties due by 2/14/2024.. Signed by Magistrate Judge Andre M. Espinosa on 6/16/2023. (ld, ) (Entered: 06/20/2023) (5)
Jun 15, 2023	166	Letter from Paul W. Kalish to the Honorable Michael E. Farbiarz, U.S.D.J.. (KALISH, PAUL) (Entered: 06/15/2023) (5)
Jun 6, 2023	N/A	Minute Entry for proceedings held before Magistrate Judge Andre M. Espinosa: Scheduling Conference held on 6/6/2023. Order to be filed. (spc) (Entered: 06/07/2023) (0)
Jun 2, 2023	165	ORDER OF WITHDRAWAL OF PRO HAC VICE COUNSEL LUKAS TOFT, ESQ. AND REQUEST FOR REMOVAL FROM RECEIVING NOTICE OF ELECTRONIC FILING; that Lukas Toft, Esq. be withdrawn as pro hac vice counsel for Defendants and Counterclaim-Plaintiffs InvaGen Pharmaceuticals, Inc., Cipla Ltd., Cipla USA, Inc., and API Pharma Tech LLC. Signed by Magistrate Judge Andre M. Espinosa on 6/2/2023. (ld, ) (Entered: 06/02/2023) (3)
Jun 1, 2023	N/A	Clerk`s Text Order - The document 161 submitted by APOTEX INC. has been GRANTED. The answer due date has been set for 6/20/2023. (sm) (Entered: 06/01/2023) (0)
Jun 1, 2023	N/A	Reset Deadlines as to 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53. Motion set for 7/3/2023 before Judge Michael E. Farbiarz. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm) (Entered: 06/01/2023) (0)
May 31, 2023	161	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to Defendant Apotex Inc.'s Answer, Affirmative Defenses and Counterclaims to Complaint for Patent Infringement (D.I. 149).. (SULLIVAN, SARAH) (Entered: 05/31/2023) (2)
May 31, 2023	162	Rule 7.1(d)(5) Letter for an automatic extension of the return date of a dispositive motion re 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53 . (KALISH, PAUL) (Entered: 05/31/2023) (2)
May 31, 2023	163	Letter from Paul W. Kalish to the Honorable Andre M. Espinosa, U.S.M.J. re: InvaGen Defendants' Notice of Withdrawal of Pro Hac Vice Attorney Lukas Toft, Esq.. (Attachments: # 1 Notice and Proposed Order)(KALISH, PAUL) (Entered: 05/31/2023) (0)
May 31, 2023	164	Joint Discovery Plan by GW RESEARCH LIMITED.(LIZZA, CHARLES) (Entered: 05/31/2023) (21)
May 30, 2023	160	Rule 7.1(d)(5) Letter for an automatic extension of the return date of a dispositive motion re 159 MOTION to Dismiss Non-Patentee Counterclaim-Defendants' Motion to Dismiss Pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and 12(b)(6), 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53 . (KALISH, PAUL) (Entered: 05/30/2023) (2)
May 30, 2023	N/A	Reset Deadlines as to 159 MOTION to Dismiss Non-Patentee Counterclaim-Defendants' Motion to Dismiss Pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and 12(b)(6). Motion set for 7/3/2023 before Judge Michael E. Farbiarz. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm) (Entered: 05/30/2023) (0)
May 26, 2023	N/A	Set Deadlines as to 158 MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53, 159 MOTION to Dismiss Non-Patentee Counterclaim-Defendants' Motion to Dismiss Pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and 12(b)(6). Motion set for 6/20/2023 before Judge Michael E. Farbiarz. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm) (Entered: 05/26/2023) (0)
May 25, 2023	157	Letter from Liza M. Walsh to the Hon. Andre M. Espinosa, U.S.M.J. re: Pro Hac Vice Application on Consent. (Attachments: # 1 Certification of Adam J. Horowitz, # 2 Certification of Liza M. Walsh, # 3 Text of Proposed Order)(WALSH, LIZA) (Entered: 05/25/2023) (0)
May 25, 2023	158	MOTION to Dismiss the InvaGen Defendants' Inequitable Conduct and Antitrust Counterclaims and to Strike Affirmative Defenses 52 and 53 by GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, GW RESEARCH LIMITED, JAZZ PHARMACEUTICALS, INC.. (Attachments: # 1 Brief, # 2 Declaration of N. LoCastro, # 3 Exhibit A (part 1), # 4 Exhibit A (part 2), # 5 Exhibit B, # 6 Exhibit C, # 7 Exhibit D, # 8 Exhibit E, # 9 Exhibit F, # 10 Text of Proposed Order, # 11 Certificate of Service)(LIZZA, CHARLES) (Entered: 05/25/2023) (0)
May 25, 2023	159	MOTION to Dismiss Non-Patentee Counterclaim-Defendants' Motion to Dismiss Pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and 12(b)(6) by GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(LIZZA, CHARLES) (Entered: 05/25/2023) (0)
May 23, 2023	156	TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Michael E. Farbiarz for all further proceedings. Judge Kevin McNulty no longer assigned to case. So Ordered by Chief Judge Renee Marie Bumb on 5/22/2023. (mfr) (Entered: 05/23/2023) (0)
May 16, 2023	N/A	Set Deadlines as to 148 MOTION for Leave to Appear Pro Hac Vice of Sri K. Sankaran. Motion set for 6/20/2023 before Judge Kevin McNulty. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm) (Entered: 05/16/2023) (0)
May 16, 2023	153	ORDER granting 148 Motion for Leave to Appear Pro Hac Vice as to SRI K. SANKARAN, ESQ.. Signed by Magistrate Judge Andre M. Espinosa on 5/16/2023. (ld, ) (Entered: 05/16/2023) (2)
May 16, 2023	154	Notice of Request by Pro Hac Vice Sri K. Sankaran to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14320385.) (Attachments: # 1 Certificate of Service)(GEWIRTZ, GREGORY) (Entered: 05/16/2023) (0)
May 16, 2023	155	AMENDED DOCUMENT by ASCENT PHARMACEUTICALS, INC.. Amendment to 154 Notice of Pro Hac Vice to Receive NEF ([Corrected] Request by Local Counsel for Pro Hac Vice Attorney to Receive Electronic Notification). (Attachments: # 1 Certificate of Service)(GEWIRTZ, GREGORY) (Entered: 05/16/2023) (0)
May 15, 2023	146	NOTICE of Appearance by GREGORY S. GEWIRTZ on behalf of ASCENT PHARMACEUTICALS, INC. (Attachments: # 1 Certificate of Service)(GEWIRTZ, GREGORY) (Entered: 05/15/2023) (0)
May 15, 2023	147	NOTICE of Appearance by HODA RIFAI-BASHJAWISH on behalf of ASCENT PHARMACEUTICALS, INC. (Attachments: # 1 Certificate of Service)(RIFAI-BASHJAWISH, HODA) (Entered: 05/15/2023) (0)
May 15, 2023	148	MOTION for Leave to Appear Pro Hac Vice of Sri K. Sankaran by ASCENT PHARMACEUTICALS, INC.. (Attachments: # 1 Certification of Gregory S. Gewirtz, # 2 Certification of Sri K. Sankaran, # 3 Text of Proposed Order, # 4 Certificate of Service)(GEWIRTZ, GREGORY) (Entered: 05/15/2023) (0)
May 15, 2023	149	ANSWER to Complaint by Apotex Inc., COUNTERCLAIM against GW RESEARCH LIMITED by APOTEX INC.. (Attachments: # 1 Corporate Disclosure)(FLAX, MELISSA) (Entered: 05/15/2023) (0)
May 15, 2023	N/A	Set/Reset Deadlines as to 148 MOTION for Leave to Appear Pro Hac Vice of Sri K. Sankaran. Motion set for 6/20/2023 before Magistrate Judge Andre M. Espinosa. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ld, ) (Entered: 05/15/2023) (0)
May 15, 2023	150	NOTICE AND ORDER OF VOLUNTARY DISMISSAL WITHOUT PREJUDICE; that, pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i), Plaintiff GW Research Limited, by and through its undersigned attorneys, hereby dismisses Counts XXI, XXII, XXIII, XXIV, XXVI, XXX, and XXXIX of its Complaint in the above-captioned matter without prejudice and without costs. No answer or motion for summary judgment has been filed with respect to these Counts by Defendant Apotex Inc., the only entity against which these Counts were asserted. All other Counts of GW Researchs Complaint (ECF No. 1) remain in the above-captioned action. Signed by Judge Kevin McNulty on 5/15/2023. (ld, ) (Entered: 05/15/2023) (2)
May 15, 2023	151	ANSWER to Complaint by ASCENT PHARMACEUTICALS, INC.. (Attachments: # 1 Certificate of Service)(GEWIRTZ, GREGORY) (Entered: 05/15/2023) (0)
May 15, 2023	152	Corporate Disclosure Statement by ASCENT PHARMACEUTICALS, INC.. (GEWIRTZ, GREGORY) (Entered: 05/15/2023) (2)
May 12, 2023	145	NOTICE of Voluntary Dismissal as to Counts XXI, XXII, XXIII, XXIV, XXVI, XXX, and XXXIX of the Complaint (D.I. 1) by GW RESEARCH LIMITED (LIZZA, CHARLES) (Entered: 05/12/2023) (2)
May 10, 2023	144	ANSWER to Counterclaim Answer to Alkem Laboratories Ltd.s Counterclaims by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 05/10/2023) (0)
Apr 19, 2023	N/A	Clerk`s Text Order - The document 139 submitted by ALKEM LABORATORIES LTD. has been GRANTED. The answer due date has been set for 5/10/2023. (sm) (Entered: 04/19/2023) (0)
Apr 18, 2023	139	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to Defendant Alkem Laboratories Ltd.'s Answer, Affirmative Defenses, and Counterclaims to Plaintiff's Complaint (D.I. 118).. (SULLIVAN, SARAH) (Entered: 04/18/2023) (2)
Apr 18, 2023	140	ANSWER to Counterclaim Answer to Teva Pharmaceuticals, Inc.'s Counterclaims by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/18/2023) (0)
Apr 18, 2023	141	ANSWER to Counterclaim Answer to Taro Pharmaceutical Industries Ltd.'s Counterclaims by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/18/2023) (0)
Apr 18, 2023	142	ANSWER to Counterclaim Answer to Lupin Limited's Counterclaims by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/18/2023) (0)
Apr 18, 2023	143	ANSWER to Counterclaim Answer to MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc.'s Counterclaims by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/18/2023) (0)
Apr 14, 2023	131	STIPULATION AND ORDER REGARDING SERVICE AND TIME FOR COUNTERCLAIM DEFENDANTS TO ANSWER, MOVE, OR OTHERWISE RESPOND TO THE INVAGEN DEFENDANTS' PLEADING; The Counterclaim Defendants shall answer, move, or otherwise respond to the InvaGen Defendants' Answer, Affirmative Defenses, and Counterclaims to GW's Complaint for Patent Infringement by May 25, 2023. Signed by Magistrate Judge Andre M. Espinosa on 4/14/2023. (ld, ) (Entered: 04/14/2023) (4)
Apr 14, 2023	132	ORDER granting 123 Motion for Leave to Appear Pro Hac Vice as to YIXIN TANG, ESQ.. Signed by Magistrate Judge Andre M. Espinosa on 4/14/2023. (ld, ) (Entered: 04/14/2023) (3)
Apr 14, 2023	133	Notice of Request by Pro Hac Vice Yixin Tang, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14247359.) (ABRAHAM, ERIC) (Entered: 04/14/2023) (1)
Apr 14, 2023	134	Notice of Request by Pro Hac Vice W. Blake Coblentz to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14247654.) (EKINER, KAAN) (Entered: 04/14/2023) (2)
Apr 14, 2023	135	Notice of Request by Pro Hac Vice Aaron S. Lukas to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14247691.) (EKINER, KAAN) (Entered: 04/14/2023) (2)
Apr 14, 2023	136	Notice of Request by Pro Hac Vice Keri L. Schaubert to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14247701.) (EKINER, KAAN) (Entered: 04/14/2023) (2)
Apr 14, 2023	137	Notice of Request by Pro Hac Vice Geng Hua to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14247708.) (EKINER, KAAN) (Entered: 04/14/2023) (2)
Apr 14, 2023	138	ANSWER to Counterclaim by GW RESEARCH LIMITED. (Attachments: # 1 Certificate of Service)(LIZZA, CHARLES) (Entered: 04/14/2023) (0)
Apr 13, 2023	123	MOTION for Leave to Appear Pro Hac Vice Yixin Tang, Esq. by MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC.. (Attachments: # 1 Certification Eric I. Abraham, Esq., # 2 Certification Yixin Tang, Esq., # 3 Text of Proposed Order)(ABRAHAM, ERIC) (Entered: 04/13/2023) (0)
Apr 13, 2023	N/A	Pro Hac Vice counsel, SHASHANK UPADHYE, ESQ., has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (ld, ) (Entered: 04/13/2023) (0)
Apr 13, 2023	N/A	Set/Reset Deadlines as to 123 MOTION for Leave to Appear Pro Hac Vice Yixin Tang, Esq.. Motion set for 5/15/2023 before Magistrate Judge Andre M. Espinosa. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ld, ) (Entered: 04/13/2023) (0)
Apr 13, 2023	124	STIPULATION AND ORDER FOR EXTENSION OF TIME FOR APOTEX INC. TO RESPOND TO COMPLAINT; The deadline by which Apotex shall answer, move, or otherwise respond to GWs Complaint for Patent Infringement is extended by 30 days, from April 13 to May 15, 2023. Signed by Magistrate Judge Andre M. Espinosa on 4/13/2023. (ld, ) (Entered: 04/13/2023) (3)
Apr 13, 2023	125	ORDER Granting Leave to Appear Pro Hac Vice as to Blake Coblentz, Esq., Aaron S. Lukas, Esq., Keri L. Schaubert, Esq., and Geng Hua, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 4/13/2023. (ld, ) (Entered: 04/13/2023) (3)
Apr 13, 2023	126	NOTICE of Appearance by CHARLES MICHAEL LIZZA on behalf of GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC. (LIZZA, CHARLES) (Entered: 04/13/2023) (2)
Apr 13, 2023	127	NOTICE of Appearance by WILLIAM C. BATON on behalf of GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC. (BATON, WILLIAM) (Entered: 04/13/2023) (2)
Apr 13, 2023	128	NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC. (SULLIVAN, SARAH) (Entered: 04/13/2023) (2)
Apr 13, 2023	129	NOTICE of Appearance by ALEXANDER LEE CALLO on behalf of GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC. (CALLO, ALEXANDER) (Entered: 04/13/2023) (2)
Apr 13, 2023	130	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (BATON, WILLIAM) (Entered: 04/13/2023) (5)
Apr 12, 2023	121	Letter from Kaan Ekiner to the Honorable Andre M. Espinosa, U.S.M.J. re Pro Hac Vice Application on Consent. (Attachments: # 1 Certification of Kaan Ekiner, # 2 Certification of W. Blake Coblentz, # 3 Certification of Aaron S. Lukas, # 4 Certification of Keri L. Schaubert, # 5 Certification of Geng Hua, # 6 Text of Proposed Order)(EKINER, KAAN) (Entered: 04/12/2023) (0)
Apr 12, 2023	N/A	Pro Hac Vice fee for Karen M. Cassidy Selvaggio, Esq., William O. Adams, Esq., and Brian C. Barnes, Esq.: $ 450, receipt number NEW48108 (jr) (Entered: 04/12/2023) (0)
Apr 12, 2023	122	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (BATON, WILLIAM) (Entered: 04/12/2023) (4)
Apr 10, 2023	120	ORDER Scheduling Initial R16 Conference set for 6/5/2023 02:30 PM before Magistrate Judge Andre M. Espinosa. Signed by Magistrate Judge Andre M. Espinosa on 4/10/2023. (spc) (Entered: 04/10/2023) (2)
Apr 5, 2023	118	ANSWER to Complaint , COUNTERCLAIM against GW RESEARCH LIMITED by ALKEM LABORATORIES LTD..(EKINER, KAAN) (Entered: 04/05/2023) (30)
Apr 5, 2023	119	Corporate Disclosure Statement by ALKEM LABORATORIES LTD.. (EKINER, KAAN) (Entered: 04/05/2023) (3)
Apr 3, 2023	116	SUMMONS ISSUED as to GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sm) (Entered: 04/03/2023) (2)
Apr 3, 2023	117	ORDER Granting Leave to Appear Pro Hac Vice as to Karen M. Cassidy Selvaggio, Esq., William O. Adams, Esq., and Brian C. Barnes, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 4/3/2023. (ld, ) (Entered: 04/03/2023) (3)
Mar 31, 2023	108	Letter from Taro Pharmaceuticals Industries Ltd to the Hon. Andre M. Espinosa, U.S.M.J. re Pro Hac Vice Application on Consent.. (Attachments: # 1 Declaration of Gregory D. Miller, # 2 Declaration of Karen M. Cassidy Selvaggio, # 3 Declaration of William O. Adams, # 4 Declaration of Brian C. Barnes, # 5 Text of Proposed Order, # 6 Certificate of Service)(MILLER, GREGORY) (Entered: 03/31/2023) (0)
Mar 31, 2023	109	Notice of Request by Pro Hac Vice Jitendra Malik to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14212784.) (RICHTER, JAMES) (Entered: 03/31/2023) (2)
Mar 31, 2023	110	ANSWER to Complaint with Affirmative Defenses, COUNTERCLAIM against GW RESEARCH LIMITED, GW PHARMACEUTICALS LIMITED, GW PHARMA LIMITED, GREENWICH BIOSCIENCES, INC., JAZZ PHARMACEUTICALS, INC. by CIPLA USA, INC., CIPLA LTD., API PHARMA TECH LLC, INVAGEN PHARMACEUTICALS, INC..(KALISH, PAUL) (Entered: 03/31/2023) (30)
Mar 31, 2023	111	Corporate Disclosure Statement by API PHARMA TECH LLC. (KALISH, PAUL) (Entered: 03/31/2023) (3)
Mar 31, 2023	112	Corporate Disclosure Statement by INVAGEN PHARMACEUTICALS, INC. identifying Cipla (EU) Limited; Cipla Ltd. as Corporate Parent.. (KALISH, PAUL) (Entered: 03/31/2023) (3)
Mar 31, 2023	113	Corporate Disclosure Statement by CIPLA LTD.. (KALISH, PAUL) (Entered: 03/31/2023) (3)
Mar 31, 2023	114	Corporate Disclosure Statement by CIPLA USA, INC. identifying INVAGEN PHARMACEUTICALS, INC.; CIPLA (EU) LIMITED; CIPLA LTD. as Corporate Parent.. (KALISH, PAUL) (Entered: 03/31/2023) (3)
Mar 31, 2023	115	Request for Summons to be Issued by INVAGEN PHARMACEUTICALS, INC., CIPLA LTD., CIPLA USA, INC., API PHARMA TECH LLC as to GREENWICH BIOSCIENCES, INC., GW PHARMA LIMITED, GW PHARMACEUTICALS LIMITED, JAZZ PHARMACEUTICALS, INC.. (KALISH, PAUL) (Entered: 03/31/2023) (1)
Mar 30, 2023	107	ORDER Granting Leave to Appear Pro Hac Vice as to Jitendra Malik, Ph.D., Esq.. Signed by Magistrate Judge Andre M. Espinosa on 3/30/2023. (ld, ) (Entered: 03/30/2023) (2)
Mar 29, 2023	106	Letter from Lupin re pro hac vice application on consent. (Attachments: # 1 Declaration of James Richter, # 2 Declaration J. Malik, # 3 Text of Proposed Order)(RICHTER, JAMES) (Entered: 03/29/2023) (0)
Mar 28, 2023	101	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to Defendant Padagis US LLC's Answer and Defenses to Complaint for Patent Infringement and Defendant's Counterclaims (D.I. 64).. (SULLIVAN, SARAH) (Entered: 03/28/2023) (2)
Mar 28, 2023	102	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to Defendant Teva Pharmaceuticals, Inc.'s Answer to Complaint, Affirmative Defenses, and Counterclaims (D.I. 76).. (SULLIVAN, SARAH) (Entered: 03/28/2023) (2)
Mar 28, 2023	103	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.'s Answer, Affirmative Defenses, and Counterclaims (D.I. 78).. (SULLIVAN, SARAH) (Entered: 03/28/2023) (2)
Mar 28, 2023	104	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to Defendant Lupin Limited's Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement (D.I. 80).. (SULLIVAN, SARAH) (Entered: 03/28/2023) (2)
Mar 28, 2023	105	Application and Proposed Order for Clerk's Order to extend time to answer as to GW's time to answer, move, or otherwise reply to Taro Pharmaceutical Industries Ltd.'s Answer to Complaint, Separate Defenses and Counterclaims (D.I. 82).. (SULLIVAN, SARAH) (Entered: 03/28/2023) (2)
Mar 28, 2023	N/A	Clerk`s Text Order - The document 101 submitted by PADAGIS US LLC has been GRANTED. The answer due date for 64 has been set for 4/14/2023. (sm) (Entered: 03/28/2023) (0)
Mar 28, 2023	N/A	Clerk`s Text Order - The document 102 submitted by GW RESEARCH LIMITED has been GRANTED. The answer due date to 76 has been set for 4/18/2023. (sm) (Entered: 03/28/2023) (0)
Mar 28, 2023	N/A	Clerk`s Text Order - The document 103 submitted by GW RESEARCH LIMITED has been GRANTED. The answer due date for 78 has been set for 4/18/2023. (sm) (Entered: 03/28/2023) (0)
Mar 28, 2023	N/A	Clerk`s Text Order - The document 104 submitted by GW RESEARCH LIMITED has been GRANTED. The answer due date for 80 has been set for 4/18/2023. (sm) (Entered: 03/28/2023) (0)
Mar 28, 2023	N/A	Clerk`s Text Order - The document 105 submitted by GW RESEARCH LIMITED has been GRANTED. The answer due date for 82 has been set for 4/18/2023. (sm) (Entered: 03/28/2023) (0)
Mar 23, 2023	96	Notice of Request by Pro Hac Vice Daryl L. Wiesen to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 03/23/2023) (2)
Mar 23, 2023	97	Notice of Request by Pro Hac Vice Jenny J. Zhang to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 03/23/2023) (2)
Mar 23, 2023	98	Notice of Request by Pro Hac Vice Gabriel Ferrante to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 03/23/2023) (2)
Mar 23, 2023	99	Notice of Request by Pro Hac Vice Madeline DiLascia to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 03/23/2023) (2)
Mar 23, 2023	100	Notice of Request by Pro Hac Vice Natasha E. Daughtrey to receive Notices of Electronic Filings. (WALSH, LIZA) (Entered: 03/23/2023) (2)
Mar 22, 2023	N/A	Pro Hac Vice fee received as to Daryl L. Wiesen, Esq., Natasha E. Daughtrey, Esq., Jenny J. Zhang, Esq., Madeline DiLascia, Esq., and Gabriel Ferrante, Esq.: $750, receipt number TRE131711 (in-cmk) (Entered: 03/22/2023) (0)
Mar 17, 2023	91	Notice of Request by Pro Hac Vice Francis D. Cerrito to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14174131.) (LIZZA, CHARLES) (Entered: 03/17/2023) (3)
Mar 17, 2023	92	Notice of Request by Pro Hac Vice Eric Stops to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14174164.) (LIZZA, CHARLES) (Entered: 03/17/2023) (3)
Mar 17, 2023	93	Notice of Request by Pro Hac Vice Daniel C. Wiesner to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14174169.) (LIZZA, CHARLES) (Entered: 03/17/2023) (3)
Mar 17, 2023	94	Notice of Request by Pro Hac Vice Gabriel P. Brier to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14174182.) (LIZZA, CHARLES) (Entered: 03/17/2023) (3)
Mar 17, 2023	95	ANSWER to Complaint (Unsealed), COUNTERCLAIM against GW RESEARCH LIMITED by MSN PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD..(ABRAHAM, ERIC) (Entered: 03/17/2023) (30)
Mar 16, 2023	N/A	Pro Hac Vice counsel, DEEPRO R. MUKERJEE, LANCE A. SODERSTROM and MATTHEW M. HOLUB, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mxw) (Entered: 03/16/2023) (0)
Mar 15, 2023	87	Notice of Request by Pro Hac Vice Deepro R. Mukerjee to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14159221.) (RICHTER, JAMES) (Entered: 03/15/2023) (2)
Mar 15, 2023	88	Notice of Request by Pro Hac Vice Lance A. Soderstrom to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14159243.) (RICHTER, JAMES) (Entered: 03/15/2023) (2)
Mar 15, 2023	89	Notice of Request by Pro Hac Vice Matthew M. Holub to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14159253.) (RICHTER, JAMES) (Entered: 03/15/2023) (2)
Mar 15, 2023	N/A	Pro Hac Vice counsel, MARK T. DEMING and CARTER KRISTEK, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (jd, ) (Entered: 03/15/2023) (0)
Mar 15, 2023	90	ORDER granting leave to appear Pro Hac Vice as to FRANCIS D. CERRITO, ESQ., ERIC STOPS, ESQ., DANIEL C. WIESNER, ESQ., AND GABRIEL P. BRIER, ESQ.. Signed by Magistrate Judge Andre M. Espinosa on 3/15/2023. (ld, ) (Entered: 03/15/2023) (3)
Mar 14, 2023	74	APPLICATION/PETITION for the Pro Hac Vice Admission of Francis D. Cerrito, Eric Stops, Daniel C. Wiesner, and Gabriel P. Brier for by GW RESEARCH LIMITED. (Attachments: # 1 Certification of C. Lizza, # 2 Certification of F. Cerrito, # 3 Certification of E. Stops, # 4 Certification of D. Wiesner, # 5 Certification of G. Brier, # 6 Text of Proposed Order)(LIZZA, CHARLES) (Entered: 03/14/2023) (0)
Mar 14, 2023	75	NOTICE of Appearance by NICHOLAS ANTHONY LOCASTRO on behalf of GW RESEARCH LIMITED (LOCASTRO, NICHOLAS) (Entered: 03/14/2023) (2)
Mar 14, 2023	76	ANSWER to Complaint , COUNTERCLAIM against GW RESEARCH LIMITED by TEVA PHARMACEUTICALS, INC..(WALSH, LIZA) (Entered: 03/14/2023) (30)
Mar 14, 2023	77	Corporate Disclosure Statement by TEVA PHARMACEUTICALS, INC.. (WALSH, LIZA) (Entered: 03/14/2023) (2)
Mar 14, 2023	78	ANSWER to Complaint with JURY DEMAND , First COUNTERCLAIM and Affirmative Defenses against All Plaintiffs by MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC..(MURTHA, WILLIAM)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 03/14/2023) (0)
Mar 14, 2023	79	Corporate Disclosure Statement by MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC. identifying MSN Laboratories Private Limited as Corporate Parent.. (MURTHA, WILLIAM) (Entered: 03/14/2023) (2)
Mar 14, 2023	80	ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against GW RESEARCH LIMITED by LUPIN LTD..(RICHTER, JAMES) (Entered: 03/14/2023) (30)
Mar 14, 2023	81	Corporate Disclosure Statement by LUPIN LTD.. (RICHTER, JAMES) (Entered: 03/14/2023) (2)
Mar 14, 2023	82	ANSWER to Complaint , COUNTERCLAIM against GW RESEARCH LIMITED by TARO PHARMACEUTICAL INDUSTRIES LTD..(MILLER, GREGORY) (Entered: 03/14/2023) (30)
Mar 14, 2023	83	Corporate Disclosure Statement by TARO PHARMACEUTICAL INDUSTRIES LTD. identifying Sun Pharmaceutical Industries, Ltd. as Corporate Parent.. (MILLER, GREGORY) (Entered: 03/14/2023) (2)
Mar 14, 2023	84	Zenara's ANSWER to Complaint of GW Research Ltd. by ZENARA PHARMA PRIVATE LTD..(SHELHOFF, DMITRY) (Entered: 03/14/2023) (30)
Mar 14, 2023	85	Corporate Disclosure Statement by BIOPHORE PHARMA, INC.. (SHELHOFF, DMITRY) (Entered: 03/14/2023) (4)
Mar 14, 2023	86	ORDER Granting Leave to Appear Pro Hac Vice as to Deepro R. Mukerjee, Esq., Lance A. Soderstrom, Esq., and Matthew M. Holub, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 3/14/2023. (ld, ) (Entered: 03/14/2023) (3)
Mar 13, 2023	68	Letter from Padagis US, LLC re 66 Letter,. (Attachments: # 1 Certification of Carter Kristek)(CONROY, REBEKAH) (Entered: 03/13/2023) (0)
Mar 13, 2023	69	STIPULATION AND ORDER FOR EXTENSION OF TIME FOR ASCENT PHARMACEUTICALS, INC. TO RESPOND TO COMPLAINT; The deadline by which Ascent shall answer, move, or otherwise respond to GW's Complaint for Patent Infringement is extended by 60 days, from March 14 to May 15, 2023. Signed by Magistrate Judge Andre M. Espinosa on 3/13/2023. (ld, ) (Entered: 03/13/2023) (2)
Mar 13, 2023	70	ORDER granting Leave to Appear Pro Hac Vice as to Mark Deming, Esq., and Carter Kristek, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 3/13/2023. (ld, ) (Entered: 03/13/2023) (2)
Mar 13, 2023	71	Notice of Request by Pro Hac Vice Mark Deming to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14150809.) (CONROY, REBEKAH) (Entered: 03/13/2023) (2)
Mar 13, 2023	72	Notice of Request by Pro Hac Vice Carter Kristek to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14150820.) (CONROY, REBEKAH) (Entered: 03/13/2023) (2)
Mar 13, 2023	73	Letter from Defendant, Lupin Ltd. re Pro Hac Vice admission of counsel on consent. (Attachments: # 1 Declaration of M. Holub, # 2 Declaration of L. Soderstrom, # 3 Declaration of D. Mukerjee, # 4 Declaration of J. Richter, # 5 Text of Proposed Order)(RICHTER, JAMES) (Entered: 03/13/2023) (0)
Mar 10, 2023	64	ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against GW RESEARCH LIMITED by PADAGIS US LLC.(CONROY, REBEKAH) (Entered: 03/10/2023) (30)
Mar 10, 2023	65	Corporate Disclosure Statement by PADAGIS US LLC. (CONROY, REBEKAH) (Entered: 03/10/2023) (2)
Mar 10, 2023	66	Letter from Defendant Padagis US LLC seeking Pro Hac Vice Admission of Counsel with Consent. (Attachments: # 1 Certification of Mark Deming, # 2 Certification of Carter Kristek, # 3 Certification of Rebekah Conroy, # 4 Text of Proposed Order Admitting Counsel Pro Hac Vice by Consent)(CONROY, REBEKAH) (Entered: 03/10/2023) (0)
Mar 10, 2023	67	Letter from GW to the Hon. Andre M. Espinosa, U.S.M.J.. (LIZZA, CHARLES) (Entered: 03/10/2023) (3)
Mar 8, 2023	62	Letter from Liza M. Walsh to the Hon. Andre M. Espinosa, U.S.M.J. re: Pro Hac Vice Application on Consent. (Attachments: # 1 Certification of Daryl L. Wiesen, # 2 Certification of Natasha E. Daughtrey, # 3 Certification of Jenny J. Zhang, # 4 Certification of Madeline DiLascia, # 5 Certification of Gabriel Ferrante, # 6 Certification of Liza M. Walsh, # 7 Text of Proposed Order)(WALSH, LIZA) (Entered: 03/08/2023) (0)
Mar 8, 2023	63	ORDER granting leave to appear pro hac vice as to Daryl L. Wiesen, Esq., Natasha E. Daughtrey, Esq., Jenny J. Zhang, Esq., Madeline DiLascia, Esq., and Gabriel Ferrante, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 3/8/2023. (ld) (Entered: 03/08/2023) (2)
Mar 7, 2023	N/A	Pro Hac Vice counsel, STEPHEN R. AUTEN, ESQ., and PHILIP Y. KOUYOUMDJIAN, ESQ., has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (ld, ) (Entered: 03/07/2023) (0)
Mar 7, 2023	59	NOTICE of Appearance by IAN SCOTT on behalf of APOTEX INC. (SCOTT, IAN) (Entered: 03/07/2023) (2)
Mar 7, 2023	60	Notice of Request by Pro Hac Vice Brent Batzer, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14137277.) (ABRAHAM, ERIC) (Entered: 03/07/2023) (1)
Mar 7, 2023	61	Notice of Request by Pro Hac Vice Shashank Upadhye, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14137301.) (ABRAHAM, ERIC) (Entered: 03/07/2023) (1)
Mar 6, 2023	49	Letter from Melissa E. Flax to Hon. Andre M. Espinosa, U.S.M.J.. (Attachments: # 1 Declaration of Stephen R. Auten in Support of Application for Admission Pro Hac Vice, # 2 Declaration of Philip Y. Kouyoumdjian in Support of Application for Admission Pro Hac Vice, # 3 Declaration of Melissa E. Flax In Support of Pro Hac Vice Admission of Counsel, # 4 Proposed Consent Order)(FLAX, MELISSA) (Entered: 03/06/2023) (0)
Mar 6, 2023	50	NOTICE of Appearance by MELISSA ELLEN FLAX on behalf of APOTEX INC. (FLAX, MELISSA) (Entered: 03/06/2023) (1)
Mar 6, 2023	51	NOTICE of Appearance by MICHAEL K. BELOSTOCK on behalf of APOTEX INC. (BELOSTOCK, MICHAEL) (Entered: 03/06/2023) (1)
Mar 6, 2023	52	STIPULATION and Proposed Order for Extension of Time for InvaGen Defendants to Respond to Complaint by API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC.. (KALISH, PAUL) (Entered: 03/06/2023) (3)
Mar 6, 2023	53	CONSENT ORDER granting leave to appear pro hac vice as to Stephen R. Auten, Esq., and Philip Y. Kouyoumdjian, Esq.. Signed by Magistrate Judge Andre M. Espinosa on 3/6/2023. (ld, ) (Entered: 03/06/2023) (3)
Mar 6, 2023	54	ORDER granting 43 Motion for Leave to Appear Pro Hac Vice as to BRENT BATZER, ESQ.. Signed by Magistrate Judge Andre M. Espinosa on 3/6/2023. (ld, ) (Entered: 03/06/2023) (2)
Mar 6, 2023	55	ORDER granting 42 Motion for Leave to Appear Pro Hac Vice as to SHASHANK UPADHYE, ESQ.. Signed by Magistrate Judge Andre M. Espinosa on 3/6/2023. (ld, ) (Entered: 03/06/2023) (2)
Mar 6, 2023	56	Notice of Request by Pro Hac Vice Stephen R. Auten to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14134576.) (FLAX, MELISSA) (Entered: 03/06/2023) (2)
Mar 6, 2023	57	Notice of Request by Pro Hac Vice Philip Y. Kouyoumdjian to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14134605.) (FLAX, MELISSA) (Entered: 03/06/2023) (2)
Mar 6, 2023	58	STIPULATION AND ORDER FOR EXTENSION OF TIME FOR INVAGEN DEFENDANTS TO RESPOND TO COMPLAINT; that the time within which the InvaGen Defendants may answer, move, or otherwise respond to Plainitff's Complaint is extended by 21 days until Monday, April 3, 2023. Signed by Magistrate Judge Andre M. Espinosa on 3/6/2023. (ld, ) (Entered: 03/07/2023) (3)
Feb 28, 2023	47	STIPULATION and Proposed Order for Extension of Time for Alkem Laboratories Ltd. to Respond to Complaint by ALKEM LABORATORIES LTD.. (EKINER, KAAN) (Entered: 02/28/2023) (2)
Feb 28, 2023	48	STIPULATION AND ORDER FOR EXTENSION OF TIME FOR ALKEM LABORATORIES LTD. TO RESPOND TO COMPLAINT; that the deadline for Alkem to move, answer, or otherwise respond to the Complaint is extended thirty (30) days to April 5, 2023. Signed by Magistrate Judge Andre M. Espinosa on 2/28/2023. (ld, ) (Entered: 02/28/2023) (2)
Feb 27, 2023	46	NOTICE of Appearance by KAAN EKINER on behalf of ALKEM LABORATORIES LTD. (EKINER, KAAN) (Entered: 02/27/2023) (3)
Feb 16, 2023	N/A	Set Deadlines as to 43 MOTION for Leave to Appear Pro Hac Vice Brent Batzer, Esq.. Motion set for 3/6/2023 before Judge Kevin McNulty. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm) (Entered: 02/16/2023) (0)
Feb 14, 2023	45	STIPULATION AND ORDER REGARDING PERSONAL JURISDICTION, VENUE, AND TIME TO ANSWER THE COMPLAINT FOR THE INVAGEN DEFENDANTS; The InvaGen Defendants will respond to the Complaint filed in the Action on or before March 13, 2023. Signed by Judge Kevin McNulty on 2/14/2023. (ld, ) (Entered: 02/14/2023) (4)
Feb 10, 2023	43	MOTION for Leave to Appear Pro Hac Vice Brent Batzer, Esq. by MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC.. (Attachments: # 1 Certification Eric I. Abraham, Esq., # 2 Certification Brent Batzer, Esq., # 3 Text of Proposed Order)(ABRAHAM, ERIC) (Entered: 02/10/2023) (0)
Feb 10, 2023	44	Letter from GW to the Hon. Kevin McNulty, U.S.D.J.. (LIZZA, CHARLES) (Entered: 02/10/2023) (5)
Feb 8, 2023	N/A	Set Deadlines as to 42 MOTION for Leave to Appear Pro Hac Vice Shashank Upadhye, Esq.. Motion set for 3/6/2023 before Judge Kevin McNulty. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (sm) (Entered: 02/08/2023) (0)
Feb 7, 2023	42	MOTION for Leave to Appear Pro Hac Vice Shashank Upadhye, Esq. by MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC.. (Attachments: # 1 Certification Eric I. Abraham, Esq., # 2 Certification Shashank Upadhye, Esq., # 3 Text of Proposed Order)(ABRAHAM, ERIC) (Entered: 02/07/2023) (0)
Feb 6, 2023	40	NOTICE of Appearance by ERIC I. ABRAHAM on behalf of MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC. (ABRAHAM, ERIC) (Entered: 02/06/2023) (2)
Feb 6, 2023	41	NOTICE of Appearance by WILLIAM MURTHA on behalf of MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC. (MURTHA, WILLIAM) (Entered: 02/06/2023) (2)
Feb 1, 2023	36	Notice of Request by Pro Hac Vice Jayashree Mitra to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13999735.) (KALISH, PAUL) (Entered: 02/01/2023) (2)
Feb 1, 2023	37	Notice of Request by Pro Hac Vice Howard S. Suh to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13999743.) (KALISH, PAUL) (Entered: 02/01/2023) (2)
Feb 1, 2023	38	Notice of Request by Pro Hac Vice Jeff E. Schwartz to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13999750.) (KALISH, PAUL) (Entered: 02/01/2023) (2)
Feb 1, 2023	39	Notice of Request by Pro Hac Vice Lukas D. Toft to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13999759.) (KALISH, PAUL) (Entered: 02/01/2023) (2)
Jan 26, 2023	32	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. ASCENT PHARMACEUTICALS, INC. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/26/2023) (1)
Jan 26, 2023	33	Application and Proposed Order for Clerk's Order to extend time to answer as to InvaGen Pharmaceuticals, Inc... (KALISH, PAUL) (Entered: 01/26/2023) (4)
Jan 26, 2023	34	Application and Proposed Order for Clerk's Order to extend time to answer as to Cipla USA, Inc... (KALISH, PAUL) (Entered: 01/26/2023) (4)
Jan 26, 2023	N/A	Clerk`s Text Order - The document 33 submitted by INVAGEN PHARMACEUTICALS, INC. has been GRANTED. The answer due date has been set for 2/23/2023. (sm) (Entered: 01/26/2023) (0)
Jan 26, 2023	N/A	Clerk`s Text Order - The document 34 submitted by CIPLA USA, INC. has been GRANTED. The answer due date has been set for 2/22/2023. (sm) (Entered: 01/26/2023) (0)
Jan 26, 2023	35	ORDER ON CONSENT GRANTING INVAGEN PHARMACEUTICALS, INC., CIPLA LTD., CIPLA USA, INC., AND API PHARMA TECH LLC'S PRO HAC VICE APPLICATION; that Jayashree Mitra, Esq., Howard S. Suh, Esq., Jeff E. Schwartz, Esq., and Lukas D. Toft, Esq., are hereby admitted pro hac vice. Signed by Magistrate Judge Andre M. Espinosa on 1/26/2023. (ld, ) (Entered: 01/26/2023) (4)
Jan 25, 2023	30	NOTICE of Appearance by PAUL W. KALISH on behalf of API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. (KALISH, PAUL) (Entered: 01/25/2023) (2)
Jan 25, 2023	31	Letter from Paul W. Kalish to Hon. Andre M. Espinosa, U.S.M.J. encl. Pro Hac Vice Application on Consent. (Attachments: # 1 Declaration of Jayashree Mitra, # 2 Declaration of Howard S. Suh, # 3 Declaration of Jeff E. Schwartz, # 4 Declaration of Lukas D. Toft, # 5 Certification of Paul W. Kalish, # 6 Text of Proposed Order)(KALISH, PAUL) (Entered: 01/25/2023) (0)
Jan 24, 2023	22	NOTICE of Appearance by KENNETH CANFIELD on behalf of BIOPHORE PHARMA, INC., ZENARA PHARMA PRIVATE LTD. (CANFIELD, KENNETH) (Entered: 01/24/2023) (2)
Jan 24, 2023	23	NOTICE of Appearance by LIZA M. WALSH on behalf of TEVA PHARMACEUTICALS, INC. (WALSH, LIZA) (Entered: 01/24/2023) (2)
Jan 24, 2023	24	NOTICE of Appearance by CHRISTINE INTROMASSO GANNON on behalf of TEVA PHARMACEUTICALS, INC. (GANNON, CHRISTINE) (Entered: 01/24/2023) (2)
Jan 24, 2023	25	NOTICE of Appearance by LAUREN RUTH MALAKOFF on behalf of TEVA PHARMACEUTICALS, INC. (MALAKOFF, LAUREN) (Entered: 01/24/2023) (2)
Jan 24, 2023	26	SUMMONS Returned Executed by GW RESEARCH LIMITED. CIPLA USA, INC. served on 1/18/2023, answer due 2/8/2023. (LIZZA, CHARLES) (Entered: 01/24/2023) (1)
Jan 24, 2023	27	SUMMONS Returned Executed by GW RESEARCH LIMITED. INVAGEN PHARMACEUTICALS, INC. served on 1/19/2023, answer due 2/9/2023. (LIZZA, CHARLES) (Entered: 01/24/2023) (1)
Jan 24, 2023	28	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. API PHARMA TECH LLC waiver sent on 1/11/2023, answer due 3/13/2023. (LIZZA, CHARLES) (Entered: 01/24/2023) (1)
Jan 24, 2023	29	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. CIPLA LTD. waiver sent on 1/11/2023, answer due 3/13/2023. (LIZZA, CHARLES) (Entered: 01/24/2023) (1)
Jan 18, 2023	18	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. MSN PHARMACEUTICALS, INC. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/18/2023) (1)
Jan 18, 2023	19	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. MSN LABORATORIES PRIVATE LTD. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/18/2023) (1)
Jan 18, 2023	20	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. APOTEX INC. waiver sent on 1/13/2023, answer due 4/13/2023. (LIZZA, CHARLES) (Entered: 01/18/2023) (1)
Jan 18, 2023	21	NOTICE of Appearance by JAMES S. RICHTER on behalf of LUPIN LTD. (RICHTER, JAMES) (Entered: 01/18/2023) (1)
Jan 17, 2023	13	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. LUPIN LTD. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/17/2023) (1)
Jan 17, 2023	14	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. ZENARA PHARMA PRIVATE LTD. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/17/2023) (1)
Jan 17, 2023	15	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. BIOPHORE PHARMA, INC. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/17/2023) (1)
Jan 17, 2023	16	NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of ZENARA PHARMA PRIVATE LTD. (SHELHOFF, DMITRY) (Entered: 01/17/2023) (3)
Jan 17, 2023	17	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. TARO PHARMACEUTICAL INDUSTRIES LTD. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/17/2023) (1)
Jan 13, 2023	12	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. TEVA PHARMACEUTICALS, INC. waiver sent on 1/13/2023, answer due 3/14/2023. (LIZZA, CHARLES) (Entered: 01/13/2023) (1)
Jan 12, 2023	10	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. ALKEM LABORATORIES LTD. waiver sent on 1/4/2023, answer due 3/6/2023. (LIZZA, CHARLES) (Entered: 01/12/2023) (1)
Jan 12, 2023	11	WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. PADAGIS US LLC waiver sent on 1/9/2023, answer due 3/10/2023. (LIZZA, CHARLES) (Entered: 01/12/2023) (1)
Jan 11, 2023	9	AO120 Patent Form filed. (Attachments: # 1 Complaint and Ex.'s A-Y) (dam) (Entered: 01/11/2023) (0)
Jan 10, 2023	7	SUMMONS ISSUED as to ALKEM LABORATORIES LTD., API PHARMA TECH LLC, APOTEX INC., ASCENT PHARMACEUTICALS, INC., BIOPHORE PHARMA, INC., CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC., LUPIN LTD., MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., PADAGIS US LLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS, INC., ZENARA PHARMA PRIVATE LTD. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sm) (Entered: 01/10/2023) (2)
Jan 10, 2023	8	AO120 Patent/Trademark Form filed. (sm) (Entered: 01/10/2023) (1)
Jan 9, 2023	6	TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Kevin McNulty for all further proceedings. Judge Susan D. Wigenton no longer assigned to case. So Ordered by Chief Judge Freda L. Wolfson on 1/9/23. (ak, ) (Entered: 01/09/2023) (0)
Jan 5, 2023	3	NOTICE of Appearance by WILLIAM C. BATON on behalf of GW RESEARCH LIMITED (BATON, WILLIAM) (Entered: 01/05/2023) (2)
Jan 5, 2023	4	NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of GW RESEARCH LIMITED (SULLIVAN, SARAH) (Entered: 01/05/2023) (2)
Jan 5, 2023	5	NOTICE of Appearance by ALEXANDER LEE CALLO on behalf of GW RESEARCH LIMITED (CALLO, ALEXANDER) (Entered: 01/05/2023) (2)
Jan 3, 2023	1	COMPLAINT against ALKEM LABORATORIES LTD., API PHARMA TECH LLC, APOTEX INC., ASCENT PHARMACEUTICALS, INC., BIOPHORE PHARMA, INC., CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC., LUPIN LTD., MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., PADAGIS US LLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS, INC., ZENARA PHARMA PRIVATE LTD. ( Filing and Admin fee $ 402 receipt number ANJDC-13932071), filed by GW RESEARCH LIMITED. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W, # 24 Exhibit X, # 25 Exhibit Y, # 26 Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 01/03/2023) (0)
Jan 3, 2023	2	Corporate Disclosure Statement by GW RESEARCH LIMITED. (LIZZA, CHARLES) (Entered: 01/03/2023) (2)
Jan 3, 2023	N/A	Case Assigned to Magistrate Judge Andre M. Espinosa. (ak, ) (Entered: 01/04/2023) (0)

Lawsuits

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al > Documents